Esperion Therapeutics | ESPR - Процентный доход





Процентный доход Изменить Дата
AbbVie USD 59M 13M 2025-12
Alnylam Pharmaceuticals USD 26.63M 2.05M 2025-12
Amarin USD 3.37M 3.37M 2024-12
Biogen USD 37.9M 700K 2026-03
BioMarin Pharmaceutical USD 19.21M 1.36M 2025-12
CSL USD 18M 1000K 2024-12
Cytokinetics USD 11.47M 1.22M 2025-12
Daiichi Sankyo JPY 9.96B 230M 2024-03
Eli Lilly USD 65M 25M 2025-09
Esperion Therapeutics USD -0.15 0.18 2024-09
Geron USD 4.26M 392K 2025-09
Heron Therapeutics USD 433K 277K 2021-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Merck USD 69M 27M 2025-12
Moderna USD 70M 3M 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Pfizer USD 166M 166M 2025-12
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 193.3M 18.2M 2025-12
Sanofi EUR 33M 81M 2025-12
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
United Therapeutics USD 46.4M 4.9M 2025-09